Compare LOW & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOW | PFE |
|---|---|---|
| Founded | 1946 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.2B | 146.5B |
| IPO Year | N/A | N/A |
| Metric | LOW | PFE |
|---|---|---|
| Price | $275.67 | $26.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 11 |
| Target Price | ★ $282.59 | $27.45 |
| AVG Volume (30 Days) | 3.0M | ★ 53.3M |
| Earning Date | 02-25-2026 | 02-03-2026 |
| Dividend Yield | 1.74% | ★ 6.42% |
| EPS Growth | ★ 0.73 | N/A |
| EPS | ★ 12.06 | 1.36 |
| Revenue | ★ $84,255,000,000.00 | $62,579,000,000.00 |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $8.19 | N/A |
| P/E Ratio | $22.87 | ★ $19.63 |
| Revenue Growth | ★ 0.64 | N/A |
| 52 Week Low | $206.39 | $20.92 |
| 52 Week High | $281.36 | $27.69 |
| Indicator | LOW | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 62.58 | 57.24 |
| Support Level | $262.67 | $25.26 |
| Resistance Level | $280.51 | $26.63 |
| Average True Range (ATR) | 6.41 | 0.56 |
| MACD | -0.76 | 0.07 |
| Stochastic Oscillator | 69.69 | 71.68 |
Lowe's is the second-largest home improvement retailer globally, with more than 1,750 stores in the US, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two-thirds of products sold. Lowe's primarily targets retail do-it-yourself (around 70% of sales) and do-it-for-me customers, but has expanded its professional business clients to 30% from less than 20% in the past six years (set ot expand further with the acquisition of FBM). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.